NCT02465268 2025-01-14
ATTAC-II
University of Florida
Phase 2 Completed
Clinical Trials
14 trialsNCT02663622 2024-01-23
MK-7110-002
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2 Completed
NCT02538341 2021-11-23
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
University of Alabama at Birmingham
Phase 2 Completed
NCT02830139 2020-03-18
Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer
Wuhan University
Phase 2 Completed
NCT02705352 2020-03-09
5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts
Massachusetts Eye and Ear Infirmary
Phase 2 Completed
NCT01687387 2019-02-08
EFFIKIR
Innate Pharma
Phase 2 Completed
NCT02731287 2018-11-14
Topical Timolol for Infantile Hemangioma in Early Proliferative Phase
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 2 Completed
NCT00614393 2018-08-08
Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT01475331 2018-03-20
The CHARM Trial: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts
Milton S. Hershey Medical Center
Phase 2 Completed
NCT03090971 2017-10-26
Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1
Fundação Educacional Serra dos Órgãos
Phase 2 Completed
NCT02675049 2016-03-01
Efficacy and Optimal Dose Selection of Intranasal Dexmedetomidine During Breast Lumpectomy Under Local Anaesthesia
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Completed
NCT00851045 2015-10-12
Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer
Bristol-Myers Squibb
Phase 2 Completed
NCT00504725 2014-07-25
KITS
Duke University
Phase 2 Completed
NCT00879775 2011-03-29
Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain
Korea Research Foundation
Phase 2 Completed